Limits...
Epidemiology of prostate cancer in South Korea.

Han HH, Park JW, Na JC, Chung BH, Kim CS, Ko WJ - Prostate Int (2015)

Bottom Line: In South Korea, PCa incidence has increased significantly, while its mortality rate has decreased steadily.PCa incidence increased significantly faster in men aged < 70 years than in the older age group.PCa prevalence in South Korea has increased significantly, mainly due to the rise in its incidence.

View Article: PubMed Central - PubMed

Affiliation: Department of Urology, National Health Insurance Service Ilsan Hospital, Yonsei University College of Medicine, Goyang, South Korea.

ABSTRACT

Background: Prostate cancer (PCa) is the second most frequently diagnosed cancer in male. In South Korea, PCa incidence has increased significantly, while its mortality rate has decreased steadily. To optimize the distribution of public medical resources, it is essential to analyze the contemporary epidemiology of PCa.

Methods: National population data from the National Health Insurance Statistical Yearbook and the annual report of national cancer registration and statistics in Korea were assessed. From the data, the incidence, prevalence, and mortality rates of PCa were calculated. The data were presented with reference to other types of cancers occurring in various countries from different continents.

Results: From 2007 to 2013, PCa incidence doubled (from 5,516 per year to 10,855 per year), while its prevalence in Korean men tripled (from 18,830 to 51,411) during the same period. The mortality rate increased slightly, from 4.2 in 2000 to 5.9 in 2007 and 6.0 in 2013 (per 100,000, age adjusted). PCa incidence increased significantly faster in men aged < 70 years than in the older age group.

Conclusion: PCa prevalence in South Korea has increased significantly, mainly due to the rise in its incidence. As the country is facing major changes, including westernization of dietary habits and rapid population aging, its prevalence would continue to increase in near future.

No MeSH data available.


Related in: MedlinePlus

Cancer incidence distribution by sites in males, in Korea in 2012. Original data available from the annual report of cancer statistics in Korea in 2012. ASR, age-standardized rate; CR, crude rate.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4588371&req=5

fig1: Cancer incidence distribution by sites in males, in Korea in 2012. Original data available from the annual report of cancer statistics in Korea in 2012. ASR, age-standardized rate; CR, crude rate.

Mentions: PCa is ranked fifth among all cancer incidences of major sites in Korean men (Fig. 1). Divided in age groups, PCa incidence increases after 60 years of age, and in those aged > 65 years, PCa is ranked fourth (Fig. 2A). International comparison of age-standardized cancer incidence rates shows that the PCa incidence rate in South Korea is similar to that in Japan (27.0 per 100,000 and 30.4 per 100,000, respectively), and still differ widely from the United States or the United Kingdom (98.2 per 100,000 and 73.2 per 100,000, respectively; Fig. 3).


Epidemiology of prostate cancer in South Korea.

Han HH, Park JW, Na JC, Chung BH, Kim CS, Ko WJ - Prostate Int (2015)

Cancer incidence distribution by sites in males, in Korea in 2012. Original data available from the annual report of cancer statistics in Korea in 2012. ASR, age-standardized rate; CR, crude rate.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4588371&req=5

fig1: Cancer incidence distribution by sites in males, in Korea in 2012. Original data available from the annual report of cancer statistics in Korea in 2012. ASR, age-standardized rate; CR, crude rate.
Mentions: PCa is ranked fifth among all cancer incidences of major sites in Korean men (Fig. 1). Divided in age groups, PCa incidence increases after 60 years of age, and in those aged > 65 years, PCa is ranked fourth (Fig. 2A). International comparison of age-standardized cancer incidence rates shows that the PCa incidence rate in South Korea is similar to that in Japan (27.0 per 100,000 and 30.4 per 100,000, respectively), and still differ widely from the United States or the United Kingdom (98.2 per 100,000 and 73.2 per 100,000, respectively; Fig. 3).

Bottom Line: In South Korea, PCa incidence has increased significantly, while its mortality rate has decreased steadily.PCa incidence increased significantly faster in men aged < 70 years than in the older age group.PCa prevalence in South Korea has increased significantly, mainly due to the rise in its incidence.

View Article: PubMed Central - PubMed

Affiliation: Department of Urology, National Health Insurance Service Ilsan Hospital, Yonsei University College of Medicine, Goyang, South Korea.

ABSTRACT

Background: Prostate cancer (PCa) is the second most frequently diagnosed cancer in male. In South Korea, PCa incidence has increased significantly, while its mortality rate has decreased steadily. To optimize the distribution of public medical resources, it is essential to analyze the contemporary epidemiology of PCa.

Methods: National population data from the National Health Insurance Statistical Yearbook and the annual report of national cancer registration and statistics in Korea were assessed. From the data, the incidence, prevalence, and mortality rates of PCa were calculated. The data were presented with reference to other types of cancers occurring in various countries from different continents.

Results: From 2007 to 2013, PCa incidence doubled (from 5,516 per year to 10,855 per year), while its prevalence in Korean men tripled (from 18,830 to 51,411) during the same period. The mortality rate increased slightly, from 4.2 in 2000 to 5.9 in 2007 and 6.0 in 2013 (per 100,000, age adjusted). PCa incidence increased significantly faster in men aged < 70 years than in the older age group.

Conclusion: PCa prevalence in South Korea has increased significantly, mainly due to the rise in its incidence. As the country is facing major changes, including westernization of dietary habits and rapid population aging, its prevalence would continue to increase in near future.

No MeSH data available.


Related in: MedlinePlus